top of page
The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Nevada in 2022.
Economic
Output
$5.5B
Direct Jobs Supported by the Industry
3,718
Total Jobs Supported by the Industry
19,268
State Total Vendor Relationships
166
State Total Vendor Spending
$194,177,886
Clinical Trials
1,093
Clinical Trial Participants
1,269,584
bottom of page